| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of
* Medical Biochemistry and
Rheumatology, Göteborg University, Göteborg, Sweden; and
Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
Collagen-induced arthritis (CIA) is an experimental animal model of human rheumatoid arthritis being characterized by synovitis and progressive destruction of cartilage and bone. CIA is induced by injection of heterologous or homologous collagen type II in a susceptible murine strain. DBA/1J mice deficient of complement factors C3 (C3-/-) and factor B (FB-/-) were generated to elucidate the role of the complement system in CIA. When immunized with bovine collagen type II emulsified in CFA, control mice developed severe arthritis and high CII-specific IgG Ab titers. In contrast, the C3-/- and FB-/- were highly resistant to CIA and displayed decreased CII-specific IgG Ab response. A repeated bovine collagen type II exposure 3 wk after the initial immunization led to an increase in the Ab response in all mice and triggered arthritis also in the complement-deficient mice. Although the arthritic score of the C3-/- mice was low, the arthritis in FB-/- mice ranked intermediate with regard to C3-/- and control mice. We conclude that complement activation by both the classical and the alternative pathway plays a deleterious role in CIA.
This article has been cited by other articles:
|
|
 |
|
  A. L. Stevens, J. S. Wishnok, F. M. White, A. J. Grodzinsky, and S. R. Tannenbaum Mechanical Injury and Cytokines Cause Loss of Cartilage Integrity and Upregulate Proteins Associated with Catabolism, Immunity, Inflammation, and Repair Mol. Cell. Proteomics, July 1, 2009; 8(7): 1475 - 1489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Ellsworth, N. Hamacher, B. Harder, K. Bannink, T. R. Bukowski, K. Byrnes-Blake, S. Underwood, C. Oliver, K. S. Waggie, C. Noriega, et al. Recombinant Soluble Human Fc{gamma}R1A (CD64A) Reduces Inflammation in Murine Collagen-Induced Arthritis J. Immunol., June 1, 2009; 182(11): 7272 - 7279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Goring, Y. Huang, C. Mowat, C. Leger, T.-H. Lim, R. Zaheer, D. Mok, L. A. Tibbles, D. Zygun, and B. W. Winston Mechanisms of human complement factor B induction in sepsis and inhibition by activated protein C Am J Physiol Cell Physiol, May 1, 2009; 296(5): C1140 - C1150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Morrison, J. D. Simmons, and M. T. Heise Complement Receptor 3 Promotes Severe Ross River Virus-Induced Disease J. Virol., November 15, 2008; 82(22): 11263 - 11272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Eggleton, R. Haigh, and P. G. Winyard Consequence of neo-antigenicity of the 'altered self' Rheumatology, May 1, 2008; 47(5): 567 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Song, F. Qiao, C. Atkinson, V. M. Holers, and S. Tomlinson A Complement C3 Inhibitor Specifically Targeted to Sites of Complement Activation Effectively Ameliorates Collagen-Induced Arthritis in DBA/1J Mice J. Immunol., December 1, 2007; 179(11): 7860 - 7867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Katschke Jr., K. Y. Helmy, M. Steffek, H. Xi, J. Yin, W. P. Lee, P. Gribling, K. H. Barck, R. A.D. Carano, R. E. Taylor, et al. A novel inhibitor of the alternative pathway of complement reverses inflammation and bone destruction in experimental arthritis J. Exp. Med., June 11, 2007; 204(6): 1319 - 1325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Morrison, R. J. Fraser, P. N. Smith, S. Mahalingam, and M. T. Heise Complement Contributes to Inflammatory Tissue Destruction in a Mouse Model of Ross River Virus-Induced Disease J. Virol., May 15, 2007; 81(10): 5132 - 5143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-F. Jegou, P. Chan, M.-T. Schouft, M. R. Griffiths, J. W. Neal, P. Gasque, H. Vaudry, and M. Fontaine C3d Binding to the Myelin Oligodendrocyte Glycoprotein Results in an Exacerbated Experimental Autoimmune Encephalomyelitis J. Immunol., March 1, 2007; 178(5): 3323 - 3331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Fusello, L. Mandik-Nayak, F. Shih, R. E. Lewis, P. M. Allen, and A. S. Shaw The MAPK Scaffold Kinase Suppressor of Ras Is Involved in ERK Activation by Stress and Proinflammatory Cytokines and Induction of Arthritis J. Immunol., November 1, 2006; 177(9): 6152 - 6158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Banda, J. M. Thurman, D. Kraus, A. Wood, M. C. Carroll, W. P. Arend, and V. M. Holers Alternative Complement Pathway Activation Is Essential for Inflammation and Joint Destruction in the Passive Transfer Model of Collagen-Induced Arthritis J. Immunol., August 1, 2006; 177(3): 1904 - 1912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Jha, J.-H. Sohn, Q. Xu, H. Nishihori, Y. Wang, S. Nishihori, B. Manickam, H. J. Kaplan, P. S. Bora, and N. S. Bora The complement system plays a critical role in the development of experimental autoimmune anterior uveitis. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1030 - 1038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Thurman and V. M. Holers The Central Role of the Alternative Complement Pathway in Human Disease J. Immunol., February 1, 2006; 176(3): 1305 - 1310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Del Nagro, R. V. Kolla, and R. C. Rickert A Critical Role for Complement C3d and the B Cell Coreceptor (CD19/CD21) Complex in the Initiation of Inflammatory Arthritis J. Immunol., October 15, 2005; 175(8): 5379 - 5389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Familian, A E Voskuyl, G J van Mierlo, H A Heijst, J W R Twisk, B A C Dijkmans, and C E Hack Infliximab treatment reduces complement activation in patients with rheumatoid arthritis Ann Rheum Dis, July 1, 2005; 64(7): 1003 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E.-K. Lee, S.-M. Kang, D.-J. Paik, J. M. Kim, and J. Youn Essential roles of Toll-like receptor-4 signaling in arthritis induced by type II collagen antibody and LPS Int. Immunol., March 1, 2005; 17(3): 325 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Li, A. Ny, G. Leonardsson, K. S. Nandakumar, R. Holmdahl, and T. Ny The Plasminogen Activator/Plasmin System Is Essential for Development of the Joint Inflammatory Phase of Collagen Type II-Induced Arthritis Am. J. Pathol., March 1, 2005; 166(3): 783 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-S. Hansson, M. Johannesson, L. Svensson, K. S. Nandakumar, D. Heinegard, and R. Holmdahl Relapsing Polychondritis, Induced in Mice with Matrilin 1, Is an Antibody- and Complement-Dependent Disease Am. J. Pathol., March 1, 2004; 164(3): 959 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Latham, A. Zamora, H. Drought, S. Subramanian, A. Matejuk, H. Offner, and E. F. Rosloniec Estradiol Treatment Redirects the Isotype of the Autoantibody Response and Prevents the Development of Autoimmune Arthritis J. Immunol., December 1, 2003; 171(11): 5820 - 5827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Banda, D. M. Kraus, M. Muggli, A. Bendele, V. M. Holers, and W. P. Arend Prevention of Collagen-Induced Arthritis in Mice Transgenic for the Complement Inhibitor Complement Receptor 1-Related Gene/Protein y J. Immunol., August 15, 2003; 171(4): 2109 - 2115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Lawrenz, R. M. Wooten, J. F. Zachary, S. M. Drouin, J. J. Weis, R. A. Wetsel, and S. J. Norris Effect of Complement Component C3 Deficiency on Experimental Lyme Borreliosis in Mice Infect. Immun., August 1, 2003; 71(8): 4432 - 4440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kagari, D. Tanaka, H. Doi, and T. Shimozato Essential Role of Fc{gamma} Receptors in Anti-Type II Collagen Antibody-Induced Arthritis J. Immunol., April 15, 2003; 170(8): 4318 - 4324. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
